Cerebral Amyloid Angiopathy and Lobar ICH - Overview and Practical Clinical Consequences

Neurology/Neurosurgery Grand Rounds

Friday January 19, 2018 at 8:00 AM


This grand round has already taken place.


HSC level 3, lecture hall 6 - Stony Brook, NY
January 19th, 2018
1.00 AMA PRA Category 1 Credit Hours

Description

Cerebral amyloid angiopathy (CAA) was once an obscure cause of intracerebral hemorrhage (ICH). Participants will learn that it currently is the second most important cause of ICH following hypertension and will continue to gain importance as our population ages.

Dates and Times

Start: 1/19/2018 8:00 AM
End: 1/19/2018 9:00 AM

Objectives

  • Participants will become familiar with the neuro imaging markers of CAA and the underlying pathophysiology which explains its clinical manifestations. They will be able to explain the important interrelationship between CAA and Alzheimer's Disease.
  • Participants will come to understand the clinical manifestations and clinical consequences of this increasingly common neurodegenerative disease of the elderly and how it impacts ischemic stroke diagnosis, stroke treatment and both ischemic and hemorrhagic stroke prevention. Several clinical cases will be used to illustrate these points.

Speakers

  • Dr. Murray Flaster
    • Cerebral Amyloid Angiopathy and Lobar ICH - Overview and Practical Clinical Consequences

Location

HSC level 3, lecture hall 6
Stony Brook Medicine
Stony Brook, NY 11794

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim the credit commensurate with the extent of their participation in the activity.